The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
The global Argatroban market was valued at US$ 63 million in 2023 and is anticipated to reach US$ 42 million by 2030, witnessing a CAGR of -5.6% during the forecast period 2024-2030.
Global Argatroban key players include Mitsubishi Tanabe Pharma, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, SANDOZ, etc. Global top four manufacturers hold a share nearly 60%.
Japan is the largest market, with a share about 35%, followed by Europe, and USA, both have a share about 55 percent.
In terms of product, Argatroban Injection is the largest segment, with a share over 70%. And in terms of application, the largest application is Heparin-induced thrombocytopenia (HIT), followed by Percutaneous Coronary Intervention, Cerebral arterial thrombosis.
This report aims to provide a comprehensive presentation of the global market for Argatroban, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Argatroban.
Report Scope
The Argatroban market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Argatroban market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Argatroban manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer, Inc
SANDOZ
GlaxoSmithKline Plc
fresenius-kabi
Eagle Pharmaceuticals, Inc
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
WEST-WARD,INC
Segment by Type
Argatroban Powder
Argatroban Injection
Segment by Application
Heparin-induced Thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral Arterial Thrombosis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Argatroban manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Argatroban in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
The global Argatroban market was valued at US$ 63 million in 2023 and is anticipated to reach US$ 42 million by 2030, witnessing a CAGR of -5.6% during the forecast period 2024-2030.
Global Argatroban key players include Mitsubishi Tanabe Pharma, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, SANDOZ, etc. Global top four manufacturers hold a share nearly 60%.
Japan is the largest market, with a share about 35%, followed by Europe, and USA, both have a share about 55 percent.
In terms of product, Argatroban Injection is the largest segment, with a share over 70%. And in terms of application, the largest application is Heparin-induced thrombocytopenia (HIT), followed by Percutaneous Coronary Intervention, Cerebral arterial thrombosis.
This report aims to provide a comprehensive presentation of the global market for Argatroban, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Argatroban.
Report Scope
The Argatroban market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Argatroban market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Argatroban manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer, Inc
SANDOZ
GlaxoSmithKline Plc
fresenius-kabi
Eagle Pharmaceuticals, Inc
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
WEST-WARD,INC
Segment by Type
Argatroban Powder
Argatroban Injection
Segment by Application
Heparin-induced Thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral Arterial Thrombosis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Argatroban manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Argatroban in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Argatroban Market Overview
1.1 Product Overview and Scope of Argatroban
1.2 Argatroban Segment by Type
1.2.1 Global Argatroban Market Value Comparison by Type (2024-2030)
1.2.2 Argatroban Powder
1.2.3 Argatroban Injection
1.3 Argatroban Segment by Application
1.3.1 Global Argatroban Market Value by Application: (2024-2030)
1.3.2 Heparin-induced Thrombocytopenia (HIT)
1.3.3 Percutaneous Coronary Intervention
1.3.4 Cerebral Arterial Thrombosis
1.4 Global Argatroban Market Size Estimates and Forecasts
1.4.1 Global Argatroban Revenue 2019-2030
1.4.2 Global Argatroban Sales 2019-2030
1.4.3 Global Argatroban Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Argatroban Market Competition by Manufacturers
2.1 Global Argatroban Sales Market Share by Manufacturers (2019-2024)
2.2 Global Argatroban Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Argatroban Average Price by Manufacturers (2019-2024)
2.4 Global Argatroban Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Argatroban, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Argatroban, Product Type & Application
2.7 Argatroban Market Competitive Situation and Trends
2.7.1 Argatroban Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Argatroban Players Market Share by Revenue
2.7.3 Global Argatroban Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Argatroban Retrospective Market Scenario by Region
3.1 Global Argatroban Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Argatroban Global Argatroban Sales by Region: 2019-2030
3.2.1 Global Argatroban Sales by Region: 2019-2024
3.2.2 Global Argatroban Sales by Region: 2025-2030
3.3 Global Argatroban Global Argatroban Revenue by Region: 2019-2030
3.3.1 Global Argatroban Revenue by Region: 2019-2024
3.3.2 Global Argatroban Revenue by Region: 2025-2030
3.4 North America Argatroban Market Facts & Figures by Country
3.4.1 North America Argatroban Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Argatroban Sales by Country (2019-2030)
3.4.3 North America Argatroban Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Argatroban Market Facts & Figures by Country
3.5.1 Europe Argatroban Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Argatroban Sales by Country (2019-2030)
3.5.3 Europe Argatroban Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Argatroban Market Facts & Figures by Country
3.6.1 Asia Pacific Argatroban Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Argatroban Sales by Country (2019-2030)
3.6.3 Asia Pacific Argatroban Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Argatroban Market Facts & Figures by Country
3.7.1 Latin America Argatroban Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Argatroban Sales by Country (2019-2030)
3.7.3 Latin America Argatroban Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Argatroban Market Facts & Figures by Country
3.8.1 Middle East and Africa Argatroban Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Argatroban Sales by Country (2019-2030)
3.8.3 Middle East and Africa Argatroban Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Argatroban Sales by Type (2019-2030)
4.1.1 Global Argatroban Sales by Type (2019-2024)
4.1.2 Global Argatroban Sales by Type (2025-2030)
4.1.3 Global Argatroban Sales Market Share by Type (2019-2030)
4.2 Global Argatroban Revenue by Type (2019-2030)
4.2.1 Global Argatroban Revenue by Type (2019-2024)
4.2.2 Global Argatroban Revenue by Type (2025-2030)
4.2.3 Global Argatroban Revenue Market Share by Type (2019-2030)
4.3 Global Argatroban Price by Type (2019-2030)
5 Segment by Application
5.1 Global Argatroban Sales by Application (2019-2030)
5.1.1 Global Argatroban Sales by Application (2019-2024)
5.1.2 Global Argatroban Sales by Application (2025-2030)
5.1.3 Global Argatroban Sales Market Share by Application (2019-2030)
5.2 Global Argatroban Revenue by Application (2019-2030)
5.2.1 Global Argatroban Revenue by Application (2019-2024)
5.2.2 Global Argatroban Revenue by Application (2025-2030)
5.2.3 Global Argatroban Revenue Market Share by Application (2019-2030)
5.3 Global Argatroban Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer, Inc
6.1.1 Pfizer, Inc Corporation Information
6.1.2 Pfizer, Inc Description and Business Overview
6.1.3 Pfizer, Inc Argatroban Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer, Inc Argatroban Product Portfolio
6.1.5 Pfizer, Inc Recent Developments/Updates
6.2 SANDOZ
6.2.1 SANDOZ Corporation Information
6.2.2 SANDOZ Description and Business Overview
6.2.3 SANDOZ Argatroban Sales, Revenue and Gross Margin (2019-2024)
6.2.4 SANDOZ Argatroban Product Portfolio
6.2.5 SANDOZ Recent Developments/Updates
6.3 GlaxoSmithKline Plc
6.3.1 GlaxoSmithKline Plc Corporation Information
6.3.2 GlaxoSmithKline Plc Description and Business Overview
6.3.3 GlaxoSmithKline Plc Argatroban Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GlaxoSmithKline Plc Argatroban Product Portfolio
6.3.5 GlaxoSmithKline Plc Recent Developments/Updates
6.4 fresenius-kabi
6.4.1 fresenius-kabi Corporation Information
6.4.2 fresenius-kabi Description and Business Overview
6.4.3 fresenius-kabi Argatroban Sales, Revenue and Gross Margin (2019-2024)
6.4.4 fresenius-kabi Argatroban Product Portfolio
6.4.5 fresenius-kabi Recent Developments/Updates
6.5 Eagle Pharmaceuticals, Inc
6.5.1 Eagle Pharmaceuticals, Inc Corporation Information
6.5.2 Eagle Pharmaceuticals, Inc Description and Business Overview
6.5.3 Eagle Pharmaceuticals, Inc Argatroban Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Eagle Pharmaceuticals, Inc Argatroban Product Portfolio
6.5.5 Eagle Pharmaceuticals, Inc Recent Developments/Updates
6.6 Mitsubishi Tanabe Pharma
6.6.1 Mitsubishi Tanabe Pharma Corporation Information
6.6.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.6.3 Mitsubishi Tanabe Pharma Argatroban Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mitsubishi Tanabe Pharma Argatroban Product Portfolio
6.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.7 Teva Pharmaceutical Industries Ltd
6.6.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Ltd Argatroban Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Pharmaceutical Industries Ltd Argatroban Product Portfolio
6.7.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.8 WEST-WARD,INC
6.8.1 WEST-WARD,INC Corporation Information
6.8.2 WEST-WARD,INC Description and Business Overview
6.8.3 WEST-WARD,INC Argatroban Sales, Revenue and Gross Margin (2019-2024)
6.8.4 WEST-WARD,INC Argatroban Product Portfolio
6.8.5 WEST-WARD,INC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Argatroban Industry Chain Analysis
7.2 Argatroban Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Argatroban Production Mode & Process
7.4 Argatroban Sales and Marketing
7.4.1 Argatroban Sales Channels
7.4.2 Argatroban Distributors
7.5 Argatroban Customers
8 Argatroban Market Dynamics
8.1 Argatroban Industry Trends
8.2 Argatroban Market Drivers
8.3 Argatroban Market Challenges
8.4 Argatroban Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
